ACC CardiaCast: What the Clinician Should Know About the Cardiac Myosin Inhibitor Mavacamten
Release Date:
In this episode, Drs. Matt Martinez and Theodore Abraham discuss “What the Clinician Should Know About the Cardiac Myosin Inhibitor Mavacamten” for the treatment of hypertrophic cardiomyopathy, and its mechanisms of action.
ACC CardiaCast: What the Clinician Should Know About the Cardiac Myosin Inhibitor Mavacamten